Scholar Rock Holding Corporation
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Scholar Rock Holding Corporation
Scholar Rock Holding Corp is a biopharmaceutical company focused on improving the lives of children and adults with Spinal Muscular Atrophy and other rare, severe, and debilitating neuromuscular diseases. Its pipeline candidates include apitegromab and a subcutaneous formulation of apitegromab. The clinical-stage pipeline also includes SRK-439, an investigational subcutaneously administered fully human anti-pro/latent myostatin antibody with high inhibitory potency and selectivity toward myostatin, being developed for the treatment of rare neuromuscular diseases. The company also maintains early-stage programs focused on therapies for rare, severe, and debilitating neuromuscular diseases.
/ 
Frequently asked questions
To buy Scholar Rock Holding Corporation stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Scholar Rock Holding Corporation by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Scholar Rock Holding Corporation is SRRK:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Scholar Rock Holding Corporation has its primary listing on NASDAQ. You can trade Scholar Rock Holding Corporation with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Scholar Rock Holding Corporation is available to trade on SaxoInvestor and SaxoTrader. You can buy shares directly and include Scholar Rock Holding Corporation as part of a broader investment portfolio.
Learn more about investing and trading in Saxo's education hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures—so you can make more informed decisions when considering shares like Scholar Rock Holding Corporation or others.